Regarding autosomal recessive LGMDs, Turan and colleagues reported the in situ correction of the mutated dysferlin gene in LGMD R2 and of the mutated SGCA gene in LGMD R3, confirming the validity of using disease-specific iPSC models to assess the correction approach (Table 2) [62]. This evidence concerns the gene DYSF and limb-girdle muscular dystrophy.